Loren Adler, Matthew Fiedler, and Benedic Ippolito offered comments on an interim final rule (IFR) issued by the Departments of Health and Human Services, Labor, and the Treasury that implements portions of the surprise billing provisions included in the No Surprises Act.
In the US health care system, payers, health systems, physicians, other clinicians, drug companies, pharmacies, and pharmacy benefit managers all earn more revenue because of administrative complexity.
Researchers are encountering increasing challenges in recruiting participants for palliative and healthcare research. This paper aims to understand challenges to and methods for engaging physicians and seriously ill patients and their caregivers in research studies.
It is unclear whether private equity investment is itself a problem or whether, in the absence of private equity, other sources of capital—such as public equity, venture capital, health systems, and insurers—would similarly exploit existing market failures and legal loopholes in the healthcare system.
Schaeffer Center Expert Joe Grogan provides background on the proposed rule – Medicare Coverage of Innovative Technologies (MCIT) – and argues eliminating MCIT would abandon attempts to jumpstart American medical device innovation while also denying patients quick access to technologies that can improve their lives and their health.